News
Q2 2025 Earnings Call Transcript July 31, 2025 Biogen Inc. misses on earnings expectations. Reported EPS is $ EPS, ...
Biogen raised its annual profit forecast and beat estimates for quarterly results on Thursday, as strong demand for its rare ...
Experts don't back specific tests, but provide guidelines on how doctors in specialty care settings can use them to diagnose ...
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...
Biogen Inc. (NASDAQ: BIIB) ranks among the stocks to benefit from an onshoring boom. On July 21, Biogen Inc. (NASDAQ:BIIB) declared that it would invest $2 billion to its existing North Carolina ...
The program was formally launched July 28 at a signing ceremony at Wake Tech’s Beltline Education Center in Raleigh. Leaders ...
The importance of a homegrown biomanufacturing workforce to North Carolina’s swiftly growing life sciences industry was a ...
"While U.S. POINTER was designed and powered as a head-to-head comparison of the two interventions, and a statistically ...
Biogen is ramping up in RTP with a fresh $2 billion investment. © 2025 American City Business Journals. All rights reserved.
Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...
Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...
AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results